biotech · Rheumatoid Arthritis · Pharmacokinetics · XBIT
XBiotech Germany
XBiotech Germany GmbH
BBT Biotech is a biotech organization headquartered in Baesweiler, DE. It trades on NYSE under ticker XBIT. Primary therapeutic focus areas include Rheumatoid Arthritis, Pharmacokinetics, Staphylococcus Aureus Bacteremia
Baesweiler, DE HQ
30 Employees
Public company Type
XBIT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Baesweiler, DE
- Employees
- 30
- Programs
- 8
- Drugs
- 6
- Patents
- 31
XB2001 or Placebo
Phase 2 · mab · Pancreatic Cancer
XB2001 or Placebo for Pancreatic Cancer is a Phase 2 program (mab) at XBiotech Germany GmbH with 1 ClinicalTrials.gov record(s).
Internal code 2020-PT049
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XBiotech Germany GmbH
- Phase
- Phase 2
- Modality
- mab
- Indication
- Pancreatic Cancer
- Status
- active
- Trials
- 1